Evidence map›Paper›PMID 41305965›Full record

ArticleHuman vaccines & immunotherapeutics2025

Human papillomavirus vaccination among childhood cancer survivors: A scoping review.

Pragya Gautam Poudel, Julia Brown, Tara M Brinkman, Casey L Daniel, Melissa M Hudson, James L Klosky, Kirsten K Ness, Heather M Brandt

Abstract readScoping Review
In one paragraph

Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pragya Gautam PoudelHPV Cancer Prevention Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
Julia BrownHPV Cancer Prevention Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
Tara M BrinkmanDepartment of Psychology and Behavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Casey L DanielCollege of Medicine, University of South Alabama, Mobile, AL, USA.
Melissa M HudsonDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA.
James L KloskyDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Kirsten K NessDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA.
Heather M BrandtHPV Cancer Prevention Program, St. Jude Children's Research Hospital, Memphis, TN, USA.

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Shondra Michelle Miller · 1985 to 2026
$166.9M
NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

Childhood cancer survivors are at increased risk for human papillomavirus (HPV) cancers yet are less likely to be vaccinated against HPV than the general population. This scoping review identified studies describing barriers, facilitators, and strategies to improve HPV vaccination in this vulnerable population. We searched PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science to identify full-length studies, published in English, from July 2006 to June 2024. We excluded survivorship studies unrelated to HPV vaccination and non-empirical studies (e.g. commentaries). Twenty studies were identified. Multi-level barriers reported occurred in patients- (e.g. vaccine safety-concerns), provider- (e.g. inconsistent guidelines), and system-levels (e.g. lack of vaccine availability). The primary facilitator was the health care provider's recommendation. Potential strategies for increased vaccination included clear recommendations and digital reminders. This review provides valuable insights for developing strategies to improve HPV vaccination coverage and reduce the risk of HPV-related cancers among childhood cancer survivors.

Indexed as

Cancer SurvivorsPapillomavirus InfectionsPapillomavirus VaccinesVaccinationAdolescentChildFemaleHuman Papillomavirus VirusesHumansVaccination CoveragePapillomavirus Vaccinesbarrierschildhood cancer survivorsfacilitatorshealth care providersHPV vaccination

Identifiers

PMID41305965
PMCPMC12667678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.